Search

everythinglearnresearchcommunity

for

Search:↓

Some drugs may increase the risk of obstructive sleep apnea, while others like certain biologics might decrease it.

A new gel form of minoxidil is equally effective for hair growth and safer for the heart and other organs than the traditional solution.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Minoxidil is strongly linked to heart problems, and machine learning can improve drug safety checks.

Gendered social factors, not just biology, contribute to sex differences in adverse drug events.

Ixekizumab has known and some unexpected side effects.

Finasteride, dutasteride, and silodosin have the highest risk for causing sexual dysfunction.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Methimazole for hyperthyroidism has known and new side effects needing more study for safety.

These migraine prevention drugs can cause side effects like constipation, hair loss, injection site reactions, fatigue, and sometimes unexpected issues like Raynaud's phenomenon and weight gain.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

Isotretinoin has many serious side effects, including some new ones, needing better safety measures and updated labels.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Family caregivers take longer to fall asleep and have more sleep disturbances, which may contribute to their health problems.

Certain existing drugs, like glycopyrronium and botulinum toxin type A, may help treat excessive sweating.

People with Alopecia Areata have more herpes simplex infections but similar rates of cancer, blood clots, and heart disease compared to those without it.

Avacopan may cause unexpected side effects, so early monitoring is important.

Dupilumab and ustekinumab are promising treatments for alopecia areata, showing significant hair regrowth.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

Minoxidil can treat hair loss with topical, oral, and sublingual options, offering personalized choices.

Low-dose finasteride may cause lasting sexual dysfunction and suicidal thoughts in young men.

5% minoxidil works better for hair growth than 1% minoxidil.

Androgen use may increase the risk of stroke, but more research is needed.

Acne is not a key diagnostic feature for PCOS, postadolescent men with acne may have insulin resistance, melanoma patients often have few moles, tumor size in CSCC indicates higher risk of serious outcomes, and hidradenitis suppurativa is linked to higher risk of heart problems and death.

Severe hair loss links to metabolic issues in older men with psoriasis.

Prostaglandin E2 affects human platelet activity in complex ways that could lead to personalized heart disease treatments.

Dupilumab is effective and safe for treating moderate-to-severe atopic dermatitis in adolescents.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

5% and 2% minoxidil solutions effectively promote hair growth and reduce hair loss, with 5% being slightly more effective but having more side effects.